Trials / Completed
CompletedNCT04833816
Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Assistance Publique Hopitaux De Marseille · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to demonstrate a significant reduction of at least 25% in opioid consumption at 48 hours of management of severe trauma, while demonstrating non-inferiority in terms of analgesia, in a group of patients receiving a continuous infusion of low dose ketamine compared to a placebo group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Administration of drug | Administration of ketamin during the 48h after trauma |
Timeline
- Start date
- 2022-08-05
- Primary completion
- 2025-10-04
- Completion
- 2026-01-03
- First posted
- 2021-04-06
- Last updated
- 2026-02-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04833816. Inclusion in this directory is not an endorsement.